HEADER    TRANSFERASE                             08-FEB-08   2VO3              
TITLE     STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH C-(4-(4-CHLOROPHENYL)-1-  
TITLE    2 (7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)PIPERIDIN-4-YL)METHYLAMINE          
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT;    
COMPND   3 CHAIN: A;                                                            
COMPND   4 SYNONYM: PROTEIN KINASE A, PKA C-ALPHA;                              
COMPND   5 EC: 2.7.11.11;                                                       
COMPND   6 ENGINEERED: YES;                                                     
COMPND   7 MUTATION: YES;                                                       
COMPND   8 MOL_ID: 2;                                                           
COMPND   9 MOLECULE: CAMP-DEPENDENT PROTEIN KINASE INHIBITOR ALPHA;             
COMPND  10 CHAIN: I;                                                            
COMPND  11 FRAGMENT: RESIDUES 6-25;                                             
COMPND  12 SYNONYM: PKI, PKI-ALPHA, CAMP- DEPENDENT PROTEIN KINASE INHIBITOR,   
COMPND  13 MUSCLE/BRAIN ISOFORM;                                                
COMPND  14 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: BOS TAURUS;                                     
SOURCE   3 ORGANISM_COMMON: BOVINE;                                             
SOURCE   4 ORGANISM_TAXID: 9913;                                                
SOURCE   5 EXPRESSION_SYSTEM: ESCHERICHIA COLI;                                 
SOURCE   6 EXPRESSION_SYSTEM_TAXID: 562;                                        
SOURCE   7 MOL_ID: 2;                                                           
SOURCE   8 SYNTHETIC: YES;                                                      
SOURCE   9 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE  10 ORGANISM_COMMON: HUMAN;                                              
SOURCE  11 ORGANISM_TAXID: 9606                                                 
KEYWDS    TRANSFERASE, LIPOPROTEIN, ATP-BINDING, PHOSPHOPROTEIN,                
KEYWDS   2 SERINE/THREONINE-PROTEIN KINASE, NUCLEOTIDE-BINDING, PROTEIN KINASE  
KEYWDS   3 INHIBITOR, CAMP, KINASE, NUCLEUS, MYRISTATE, CYTOPLASM               
EXPDTA    X-RAY DIFFRACTION                                                     
AUTHOR    J.J.CALDWELL,T.G.DAVIES,A.DONALD,T.MCHARDY,M.G.ROWLANDS,G.W.AHERNE,   
AUTHOR   2 L.K.HUNTER,K.TAYLOR,R.RUDDLE,F.I.RAYNAUD,M.VERDONK,P.WORKMAN,        
AUTHOR   3 M.D.GARRETT,I.COLLINS                                                
REVDAT   4   23-OCT-24 2VO3    1       LINK                                     
REVDAT   3   24-FEB-09 2VO3    1       VERSN                                    
REVDAT   2   29-APR-08 2VO3    1       JRNL   REMARK                            
REVDAT   1   08-APR-08 2VO3    0                                                
JRNL        AUTH   J.J.CALDWELL,T.G.DAVIES,A.DONALD,T.MCHARDY,M.G.ROWLANDS,     
JRNL        AUTH 2 G.W.AHERNE,L.K.HUNTER,K.TAYLOR,R.RUDDLE,F.I.RAYNAUD,         
JRNL        AUTH 3 M.VERDONK,P.WORKMAN,M.D.GARRETT,I.COLLINS                    
JRNL        TITL   IDENTIFICATION OF                                            
JRNL        TITL 2 4-(4-AMINOPIPERIDIN-1-YL)-7H-PYRROLO[2,3-D]PYRIMIDINES AS    
JRNL        TITL 3 SELECTIVE INHIBITORS OF PROTEIN KINASE B THROUGH FRAGMENT    
JRNL        TITL 4 ELABORATION.                                                 
JRNL        REF    J.MED.CHEM.                   V.  51  2147 2008              
JRNL        REFN                   ISSN 0022-2623                               
JRNL        PMID   18345609                                                     
JRNL        DOI    10.1021/JM701437D                                            
REMARK   2                                                                      
REMARK   2 RESOLUTION.    1.98 ANGSTROMS.                                       
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : REFMAC 5.2.0019I                                     
REMARK   3   AUTHORS     : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,              
REMARK   3               : NICHOLLS,WINN,LONG,VAGIN                             
REMARK   3                                                                      
REMARK   3    REFINEMENT TARGET : MAXIMUM LIKELIHOOD                            
REMARK   3                                                                      
REMARK   3  DATA USED IN REFINEMENT.                                            
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 1.98                           
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 33.18                          
REMARK   3   DATA CUTOFF            (SIGMA(F)) : NULL                           
REMARK   3   COMPLETENESS FOR RANGE        (%) : 97.4                           
REMARK   3   NUMBER OF REFLECTIONS             : 28726                          
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT.                                     
REMARK   3   CROSS-VALIDATION METHOD          : THROUGHOUT                      
REMARK   3   FREE R VALUE TEST SET SELECTION  : RANDOM                          
REMARK   3   R VALUE     (WORKING + TEST SET) : 0.189                           
REMARK   3   R VALUE            (WORKING SET) : 0.186                           
REMARK   3   FREE R VALUE                     : 0.246                           
REMARK   3   FREE R VALUE TEST SET SIZE   (%) : 5.100                           
REMARK   3   FREE R VALUE TEST SET COUNT      : 1538                            
REMARK   3                                                                      
REMARK   3  FIT IN THE HIGHEST RESOLUTION BIN.                                  
REMARK   3   TOTAL NUMBER OF BINS USED           : 20                           
REMARK   3   BIN RESOLUTION RANGE HIGH       (A) : 1.98                         
REMARK   3   BIN RESOLUTION RANGE LOW        (A) : 2.03                         
REMARK   3   REFLECTION IN BIN     (WORKING SET) : 1817                         
REMARK   3   BIN COMPLETENESS (WORKING+TEST) (%) : NULL                         
REMARK   3   BIN R VALUE           (WORKING SET) : 0.2620                       
REMARK   3   BIN FREE R VALUE SET COUNT          : 114                          
REMARK   3   BIN FREE R VALUE                    : 0.3210                       
REMARK   3                                                                      
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    
REMARK   3   PROTEIN ATOMS            : 2945                                    
REMARK   3   NUCLEIC ACID ATOMS       : 0                                       
REMARK   3   HETEROGEN ATOMS          : 26                                      
REMARK   3   SOLVENT ATOMS            : 341                                     
REMARK   3                                                                      
REMARK   3  B VALUES.                                                           
REMARK   3   FROM WILSON PLOT           (A**2) : NULL                           
REMARK   3   MEAN B VALUE      (OVERALL, A**2) : 21.51                          
REMARK   3   OVERALL ANISOTROPIC B VALUE.                                       
REMARK   3    B11 (A**2) : 0.76000                                              
REMARK   3    B22 (A**2) : 0.42000                                              
REMARK   3    B33 (A**2) : -1.18000                                             
REMARK   3    B12 (A**2) : 0.00000                                              
REMARK   3    B13 (A**2) : 0.00000                                              
REMARK   3    B23 (A**2) : 0.00000                                              
REMARK   3                                                                      
REMARK   3  ESTIMATED OVERALL COORDINATE ERROR.                                 
REMARK   3   ESU BASED ON R VALUE                            (A): 0.175         
REMARK   3   ESU BASED ON FREE R VALUE                       (A): 0.170         
REMARK   3   ESU BASED ON MAXIMUM LIKELIHOOD                 (A): 0.116         
REMARK   3   ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.060         
REMARK   3                                                                      
REMARK   3 CORRELATION COEFFICIENTS.                                            
REMARK   3   CORRELATION COEFFICIENT FO-FC      : 0.951                         
REMARK   3   CORRELATION COEFFICIENT FO-FC FREE : 0.919                         
REMARK   3                                                                      
REMARK   3  RMS DEVIATIONS FROM IDEAL VALUES        COUNT    RMS    WEIGHT      
REMARK   3   BOND LENGTHS REFINED ATOMS        (A):  3048 ; 0.013 ; 0.022       
REMARK   3   BOND LENGTHS OTHERS               (A):  2135 ; 0.001 ; 0.020       
REMARK   3   BOND ANGLES REFINED ATOMS   (DEGREES):  4116 ; 1.299 ; 1.953       
REMARK   3   BOND ANGLES OTHERS          (DEGREES):  5169 ; 0.887 ; 2.990       
REMARK   3   TORSION ANGLES, PERIOD 1    (DEGREES):   355 ; 5.644 ; 5.000       
REMARK   3   TORSION ANGLES, PERIOD 2    (DEGREES):   151 ;37.806 ;23.841       
REMARK   3   TORSION ANGLES, PERIOD 3    (DEGREES):   541 ;14.466 ;15.055       
REMARK   3   TORSION ANGLES, PERIOD 4    (DEGREES):    18 ;22.249 ;15.000       
REMARK   3   CHIRAL-CENTER RESTRAINTS       (A**3):   423 ; 0.080 ; 0.200       
REMARK   3   GENERAL PLANES REFINED ATOMS      (A):  3333 ; 0.005 ; 0.020       
REMARK   3   GENERAL PLANES OTHERS             (A):   661 ; 0.001 ; 0.020       
REMARK   3   NON-BONDED CONTACTS REFINED ATOMS (A):   625 ; 0.204 ; 0.200       
REMARK   3   NON-BONDED CONTACTS OTHERS        (A):  2236 ; 0.194 ; 0.200       
REMARK   3   NON-BONDED TORSION REFINED ATOMS  (A):  1475 ; 0.184 ; 0.200       
REMARK   3   NON-BONDED TORSION OTHERS         (A):  1519 ; 0.083 ; 0.200       
REMARK   3   H-BOND (X...Y) REFINED ATOMS      (A):    69 ; 0.108 ; 0.200       
REMARK   3   H-BOND (X...Y) OTHERS             (A):  NULL ;  NULL ;  NULL       
REMARK   3   POTENTIAL METAL-ION REFINED ATOMS (A):  NULL ;  NULL ;  NULL       
REMARK   3   POTENTIAL METAL-ION OTHERS        (A):  NULL ;  NULL ;  NULL       
REMARK   3   SYMMETRY VDW REFINED ATOMS        (A):     3 ; 0.065 ; 0.200       
REMARK   3   SYMMETRY VDW OTHERS               (A):    22 ; 0.278 ; 0.200       
REMARK   3   SYMMETRY H-BOND REFINED ATOMS     (A):     3 ; 0.122 ; 0.200       
REMARK   3   SYMMETRY H-BOND OTHERS            (A):  NULL ;  NULL ;  NULL       
REMARK   3   SYMMETRY METAL-ION REFINED ATOMS  (A):  NULL ;  NULL ;  NULL       
REMARK   3   SYMMETRY METAL-ION OTHERS         (A):  NULL ;  NULL ;  NULL       
REMARK   3                                                                      
REMARK   3  ISOTROPIC THERMAL FACTOR RESTRAINTS.     COUNT   RMS    WEIGHT      
REMARK   3   MAIN-CHAIN BOND REFINED ATOMS  (A**2):  1777 ; 0.077 ; 5.000       
REMARK   3   MAIN-CHAIN BOND OTHER ATOMS    (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   MAIN-CHAIN ANGLE REFINED ATOMS (A**2):  2866 ; 0.101 ; 6.000       
REMARK   3   MAIN-CHAIN ANGLE OTHER ATOMS   (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   SIDE-CHAIN BOND REFINED ATOMS  (A**2):  1271 ; 0.098 ; 6.000       
REMARK   3   SIDE-CHAIN BOND OTHER ATOMS    (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   SIDE-CHAIN ANGLE REFINED ATOMS (A**2):  1250 ; 0.121 ; 7.500       
REMARK   3   SIDE-CHAIN ANGLE OTHER ATOMS   (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   LONG RANGE B REFINED ATOMS     (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   LONG RANGE B OTHER ATOMS       (A**2):  NULL ;  NULL ;  NULL       
REMARK   3                                                                      
REMARK   3 ANISOTROPIC THERMAL FACTOR RESTRAINTS.    COUNT   RMS   WEIGHT       
REMARK   3   RIGID-BOND RESTRAINTS          (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   SPHERICITY; FREE ATOMS         (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   SPHERICITY; BONDED ATOMS       (A**2):  NULL ;  NULL ;  NULL       
REMARK   3                                                                      
REMARK   3  NCS RESTRAINTS STATISTICS                                           
REMARK   3   NUMBER OF DIFFERENT NCS GROUPS : NULL                              
REMARK   3                                                                      
REMARK   3  TLS DETAILS                                                         
REMARK   3   NUMBER OF TLS GROUPS  : NULL                                       
REMARK   3                                                                      
REMARK   3  BULK SOLVENT MODELLING.                                             
REMARK   3   METHOD USED : BABINET MODEL WITH MASK                              
REMARK   3   PARAMETERS FOR MASK CALCULATION                                    
REMARK   3   VDW PROBE RADIUS   : 1.20                                          
REMARK   3   ION PROBE RADIUS   : 0.80                                          
REMARK   3   SHRINKAGE RADIUS   : 0.80                                          
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING   
REMARK   3  POSITIONS. ALTHOUGH THERE IS EVIDENCE FOR A SECOND INHIBITOR        
REMARK   3  BINDING SITE NEAR LYS 292, ONLY THE PYRROLO- PYRIMIDINE MOIETY      
REMARK   3  COULD BE FITTED WITH CONFIDENCE, AND SO THIS SITE HAS NOT BEEN      
REMARK   3  BUILT IN THE FINAL MODEL.                                           
REMARK   4                                                                      
REMARK   4 2VO3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 08-FEB-08.                  
REMARK 100 THE DEPOSITION ID IS D_1290035286.                                   
REMARK 200                                                                      
REMARK 200 EXPERIMENTAL DETAILS                                                 
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  
REMARK 200  DATE OF DATA COLLECTION        : NULL                               
REMARK 200  TEMPERATURE           (KELVIN) : 100                                
REMARK 200  PH                             : NULL                               
REMARK 200  NUMBER OF CRYSTALS USED        : NULL                               
REMARK 200                                                                      
REMARK 200  SYNCHROTRON              (Y/N) : N                                  
REMARK 200  RADIATION SOURCE               : ROTATING ANODE                     
REMARK 200  BEAMLINE                       : NULL                               
REMARK 200  X-RAY GENERATOR MODEL          : RIGAKU RUH3R                       
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M                                  
REMARK 200  WAVELENGTH OR RANGE        (A) : 1.5418                             
REMARK 200  MONOCHROMATOR                  : NULL                               
REMARK 200  OPTICS                         : NULL                               
REMARK 200                                                                      
REMARK 200  DETECTOR TYPE                  : CCD                                
REMARK 200  DETECTOR MANUFACTURER          : RIGAKU CCD                         
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : NULL                               
REMARK 200  DATA SCALING SOFTWARE          : NULL                               
REMARK 200                                                                      
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 28726                              
REMARK 200  RESOLUTION RANGE HIGH      (A) : 1.980                              
REMARK 200  RESOLUTION RANGE LOW       (A) : 33.000                             
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : NULL                               
REMARK 200                                                                      
REMARK 200 OVERALL.                                                             
REMARK 200  COMPLETENESS FOR RANGE     (%) : 97.2                               
REMARK 200  DATA REDUNDANCY                : 2.400                              
REMARK 200  R MERGE                    (I) : 0.05000                            
REMARK 200  R SYM                      (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR THE DATA SET  : NULL                               
REMARK 200                                                                      
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.                                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.98                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 2.08                     
REMARK 200  COMPLETENESS FOR SHELL     (%) : 90.2                               
REMARK 200  DATA REDUNDANCY IN SHELL       : NULL                               
REMARK 200  R MERGE FOR SHELL          (I) : 0.23000                            
REMARK 200  R SYM FOR SHELL            (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR SHELL         : 3.100                              
REMARK 200                                                                      
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH                              
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT        
REMARK 200 SOFTWARE USED: NULL                                                  
REMARK 200 STARTING MODEL: NULL                                                 
REMARK 200                                                                      
REMARK 200 REMARK: NONE                                                         
REMARK 280                                                                      
REMARK 280 CRYSTAL                                                              
REMARK 280 SOLVENT CONTENT, VS   (%): 47.18                                     
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.35                     
REMARK 280                                                                      
REMARK 280 CRYSTALLIZATION CONDITIONS: NULL                                     
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY                                            
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21                       
REMARK 290                                                                      
REMARK 290      SYMOP   SYMMETRY                                                
REMARK 290     NNNMMM   OPERATOR                                                
REMARK 290       1555   X,Y,Z                                                   
REMARK 290       2555   -X+1/2,-Y,Z+1/2                                         
REMARK 290       3555   -X,Y+1/2,-Z+1/2                                         
REMARK 290       4555   X+1/2,-Y+1/2,-Z                                         
REMARK 290                                                                      
REMARK 290     WHERE NNN -> OPERATOR NUMBER                                     
REMARK 290           MMM -> TRANSLATION VECTOR                                  
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
REMARK 290 RELATED MOLECULES.                                                   
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000       36.56200            
REMARK 290   SMTRY2   2  0.000000 -1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   2  0.000000  0.000000  1.000000       39.96650            
REMARK 290   SMTRY1   3 -1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   3  0.000000  1.000000  0.000000       37.23850            
REMARK 290   SMTRY3   3  0.000000  0.000000 -1.000000       39.96650            
REMARK 290   SMTRY1   4  1.000000  0.000000  0.000000       36.56200            
REMARK 290   SMTRY2   4  0.000000 -1.000000  0.000000       37.23850            
REMARK 290   SMTRY3   4  0.000000  0.000000 -1.000000        0.00000            
REMARK 290                                                                      
REMARK 290 REMARK: NULL                                                         
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC                    
REMARK 350 SOFTWARE USED: PQS                                                   
REMARK 350 TOTAL BURIED SURFACE AREA: 2250 ANGSTROM**2                          
REMARK 350 SURFACE AREA OF THE COMPLEX: 19840 ANGSTROM**2                       
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -5.8 KCAL/MOL                         
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, I                                  
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 400                                                                      
REMARK 400 COMPOUND                                                             
REMARK 400 ENGINEERED RESIDUE IN CHAIN A, VAL 105 TO THR                        
REMARK 400 ENGINEERED RESIDUE IN CHAIN A, VAL 124 TO ALA                        
REMARK 400 ENGINEERED RESIDUE IN CHAIN A, LEU 174 TO MET                        
REMARK 400 ENGINEERED RESIDUE IN CHAIN A, GLN 182 TO LYS                        
REMARK 465                                                                      
REMARK 465 MISSING RESIDUES                                                     
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE                       
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)                
REMARK 465                                                                      
REMARK 465   M RES C SSSEQI                                                     
REMARK 465     MET A     0                                                      
REMARK 465     GLY A     1                                                      
REMARK 465     ASN A     2                                                      
REMARK 465     ALA A     3                                                      
REMARK 465     ALA A     4                                                      
REMARK 465     ALA A     5                                                      
REMARK 465     ALA A     6                                                      
REMARK 465     LYS A     7                                                      
REMARK 465     LYS A     8                                                      
REMARK 465     GLY A     9                                                      
REMARK 465     SER A    10                                                      
REMARK 465     GLU A    11                                                      
REMARK 465     GLN A    12                                                      
REMARK 465     GLU A    13                                                      
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500    ASN A  99      115.80   -163.01                                   
REMARK 500    ASP A 166       54.00   -151.90                                   
REMARK 500    THR A 183     -162.63   -103.33                                   
REMARK 500    SER A 252      -38.35    -39.00                                   
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 525                                                                      
REMARK 525 SOLVENT                                                              
REMARK 525                                                                      
REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT                    
REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST                  
REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT                 
REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE                       
REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER;                             
REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE                  
REMARK 525 NUMBER; I=INSERTION CODE):                                           
REMARK 525                                                                      
REMARK 525  M RES CSSEQI                                                        
REMARK 525    HOH A2010        DISTANCE =  6.73 ANGSTROMS                       
REMARK 800                                                                      
REMARK 800 SITE                                                                 
REMARK 800 SITE_IDENTIFIER: AC1                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A1351                  
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC2                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE M04 A1352                 
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 1XH6   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORSIN        
REMARK 900 COMPLEX WITH PROTEIN KINASE A AND MUTANTS                            
REMARK 900 RELATED ID: 1XH9   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORSIN        
REMARK 900 COMPLEX WITH PROTEIN KINASE A AND MUTANTS                            
REMARK 900 RELATED ID: 2VNW   RELATED DB: PDB                                   
REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH (1-(9H-PURIN-6-YL)       
REMARK 900 PIPERIDIN-4-YL) METHANAMINE                                          
REMARK 900 RELATED ID: 1YDR   RELATED DB: PDB                                   
REMARK 900 STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTICSUBUNIT   
REMARK 900 IN COMPLEX WITH H7 PROTEIN KINASE INHIBITOR1-(5-                     
REMARK 900 ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE                             
REMARK 900 RELATED ID: 1SVE   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITHAZEPANE         
REMARK 900 DERIVATIVE 1                                                         
REMARK 900 RELATED ID: 2UVZ   RELATED DB: PDB                                   
REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH C-PHENYL-C-(4-(9H-PURIN- 
REMARK 900 6-YL)-PHENYL )-METHYLAMINE                                           
REMARK 900 RELATED ID: 1XH4   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORSIN        
REMARK 900 COMPLEX WITH PROTEIN KINASE A AND MUTANTS                            
REMARK 900 RELATED ID: 2UVX   RELATED DB: PDB                                   
REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 7-AZAINDOLE              
REMARK 900 RELATED ID: 1Q8U   RELATED DB: PDB                                   
REMARK 900 THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE INCOMPLEX     
REMARK 900 WITH RHO-KINASE INHIBITOR H-1152P                                    
REMARK 900 RELATED ID: 2F7E   RELATED DB: PDB                                   
REMARK 900 PKA COMPLEXED WITH (S)-2-(1H-INDOL-3-YL )-1-(5-ISOQUINOLIN-6-YL-     
REMARK 900 PYRIDIN-3- YLOXYMETHYL-ETYLAMINE                                     
REMARK 900 RELATED ID: 2VO6   RELATED DB: PDB                                   
REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 4-(4-CHLOROBENZYL)-1-    
REMARK 900 (7H-PYRROLO(2,3-D )PYRIMIDIN-4-YL)PIPERIDIN-4-YLAMINE                
REMARK 900 RELATED ID: 1KMU   RELATED DB: PDB                                   
REMARK 900 MODEL STRUCTURE OF THE CATALYTIC SUBUNIT- REGULATORY SUBUNITDIMERIC  
REMARK 900 COMPLEX OF THE CAMP -DEPENDENT PROTEIN KINASE                        
REMARK 900 RELATED ID: 1CMK   RELATED DB: PDB                                   
REMARK 900 RELATED ID: 2UW7   RELATED DB: PDB                                   
REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 4-(4-CHLORO-PHENYL)-4-   
REMARK 900 (4-(1H-PYRAZOL-4 -YL)-PHENYL)-PIPERIDINE                             
REMARK 900 RELATED ID: 2JDS   RELATED DB: PDB                                   
REMARK 900 STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH A-443654   
REMARK 900 RELATED ID: 1Q62   RELATED DB: PDB                                   
REMARK 900 PKA DOUBLE MUTANT MODEL OF PKB                                       
REMARK 900 RELATED ID: 2UW8   RELATED DB: PDB                                   
REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 2-(4-CHLORO-PHENYL)-2-   
REMARK 900 PHENYL-ETHYLAMINE                                                    
REMARK 900 RELATED ID: 2GNF   RELATED DB: PDB                                   
REMARK 900 PROTEIN KINASE A FIVEFOLD MUTANT MODEL OF RHO-KINASE WITH Y-27632    
REMARK 900 RELATED ID: 2UZU   RELATED DB: PDB                                   
REMARK 900 PKA STRUCTURES OF INDAZOLE-PYRIDINE SERIES OF AKT INHIBITORS         
REMARK 900 RELATED ID: 2UW3   RELATED DB: PDB                                   
REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 5-METHYL-4-PHENYL-1H-    
REMARK 900 PYRAZOLE                                                             
REMARK 900 RELATED ID: 2C1A   RELATED DB: PDB                                   
REMARK 900 STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH            
REMARK 900 ISOQUINOLINE-5-SULFONIC ACID ( 2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)   
REMARK 900 ETHYL) AMIDE                                                         
REMARK 900 RELATED ID: 1SMH   RELATED DB: PDB                                   
REMARK 900 PROTEIN KINASE A VARIANT COMPLEX WITH COMPLETELY ORDERED N-TERMINAL  
REMARK 900 HELIX                                                                
REMARK 900 RELATED ID: 2UW4   RELATED DB: PDB                                   
REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 2-(4-(5-METHYL-1H-       
REMARK 900 PYRAZOL-4-YL)-PHENYL )-ETHYLAMINE                                    
REMARK 900 RELATED ID: 1VEB   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITHAZEPANE         
REMARK 900 DERIVATIVE 5                                                         
REMARK 900 RELATED ID: 2C1B   RELATED DB: PDB                                   
REMARK 900 STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH (4R,2S)-5' 
REMARK 900 -(4-(4- CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL) ISOQUINOLINE 
REMARK 900 RELATED ID: 2GNL   RELATED DB: PDB                                   
REMARK 900 PKA THREEFOLD MUTANT MODEL OF RHO-KINASE WITH INHIBITOR H-1152P      
REMARK 900 RELATED ID: 1JLU   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT         
REMARK 900 PROTEIN KINASE COMPLEXED WITH A PHOSPHORYLATEDSUBSTRATE PEPTIDE AND  
REMARK 900 DETERGENT                                                            
REMARK 900 RELATED ID: 1XH7   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORSIN        
REMARK 900 COMPLEX WITH PROTEIN KINASE A AND MUTANTS                            
REMARK 900 RELATED ID: 2UZV   RELATED DB: PDB                                   
REMARK 900 PKA STRUCTURES OF INDAZOLE-PYRIDINE SERIES OF AKT INHIBITORS         
REMARK 900 RELATED ID: 1Q24   RELATED DB: PDB                                   
REMARK 900 PKA DOUBLE MUTANT MODEL OF PKB IN COMPLEX WITH MGATP                 
REMARK 900 RELATED ID: 2VNY   RELATED DB: PDB                                   
REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH (1-(9H-PURIN-6-YL)       
REMARK 900 PIPERIDIN-4-YL)AMINE                                                 
REMARK 900 RELATED ID: 2UW6   RELATED DB: PDB                                   
REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH (S)-2-(4-CHLORO-PHENYL)- 
REMARK 900 2-(4-1H- PYRAZOL-4-YL)-PHENYL)-ETHYLAMINE                            
REMARK 900 RELATED ID: 1SVG   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITHAZEPANE         
REMARK 900 DERIVATIVE 4                                                         
REMARK 900 RELATED ID: 1KMW   RELATED DB: PDB                                   
REMARK 900 MODEL STRUCTURE OF THE CATALYTIC SUBUNIT- REGULATORY SUBUNITDIMERIC  
REMARK 900 COMPLEX OF THE C- AMP-DEPENDENT PROTEIN KINASE                       
REMARK 900 RELATED ID: 1XHA   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORSIN        
REMARK 900 COMPLEX WITH PROTEIN KINASE A AND MUTANTS                            
REMARK 900 RELATED ID: 2GNJ   RELATED DB: PDB                                   
REMARK 900 PKA THREE FOLD MUTANT MODEL OF RHO-KINASE WITH Y-27632               
REMARK 900 RELATED ID: 2UVY   RELATED DB: PDB                                   
REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH METHYL-(4-(9H-PURIN-6-   
REMARK 900 YL)-BENZYL)-AMINE                                                    
REMARK 900 RELATED ID: 2VO0   RELATED DB: PDB                                   
REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH C-(4-(4-CHLOROPHENYL)-1- 
REMARK 900 (7H-PYRROLO(2, 3-D)PYRIMIDIN-4-YL)PIPERIDIN-4-YL) METHYLAMINE        
REMARK 900 RELATED ID: 2GNH   RELATED DB: PDB                                   
REMARK 900 PKA FIVE FOLD MUTANT MODEL OF RHO-KINASE WITH H1152P                 
REMARK 900 RELATED ID: 2GFC   RELATED DB: PDB                                   
REMARK 900 CAMP-DEPENDENT PROTEIN KINASE PKA CATALYTIC SUBUNIT WITHPKI-5-24     
REMARK 900 RELATED ID: 1SZM   RELATED DB: PDB                                   
REMARK 900 DUAL BINDING MODE OF BISINDOLYLMALEIMIDE 2 TO PROTEINKINASE A (PKA)  
REMARK 900 RELATED ID: 1Q61   RELATED DB: PDB                                   
REMARK 900 PKA TRIPLE MUTANT MODEL OF PKB                                       
REMARK 900 RELATED ID: 2GNG   RELATED DB: PDB                                   
REMARK 900 PROTEIN KINASE A FIVEFOLD MUTANT MODEL OF RHO-KINASE                 
REMARK 900 RELATED ID: 1YDT   RELATED DB: PDB                                   
REMARK 900 STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTICSUBUNIT   
REMARK 900 IN COMPLEX WITH H89 PROTEIN KINASE INHIBITORN-[2-(4-                 
REMARK 900 BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE                             
REMARK 900 RELATED ID: 2UZT   RELATED DB: PDB                                   
REMARK 900 PKA STRUCTURES OF AKT, INDAZOLE-PYRIDINE INHIBITORS                  
REMARK 900 RELATED ID: 1Q8W   RELATED DB: PDB                                   
REMARK 900 THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE INCOMPLEX     
REMARK 900 WITH RHO-KINASE INHIBITOR FASUDIL (HA-1077)                          
REMARK 900 RELATED ID: 1SVH   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITHAZEPANE         
REMARK 900 DERIVATIVE 8                                                         
REMARK 900 RELATED ID: 2UZW   RELATED DB: PDB                                   
REMARK 900 PKA STRUCTURES OF INDAZOLE-PYRIDINE SERIES OF AKT INHIBITORS         
REMARK 900 RELATED ID: 2UW0   RELATED DB: PDB                                   
REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 6-(4-(4-(4-CHLORO-       
REMARK 900 PHENYL)-PIPERIDIN-4- YL)-PHENYL)-9H-PURINE                           
REMARK 900 RELATED ID: 2JDV   RELATED DB: PDB                                   
REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH A-443654                 
REMARK 900 RELATED ID: 2UW5   RELATED DB: PDB                                   
REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH (R)-2-(4-CHLORO-PHENYL)- 
REMARK 900 2-(4-1H- PYRAZOL-4-YL)-PHENYL)-ETHYLAMINE                            
REMARK 900 RELATED ID: 2GNI   RELATED DB: PDB                                   
REMARK 900 PKA FIVEFOLD MUTANT MODEL OF RHO-KINASE WITH INHIBITORFASUDIL        
REMARK 900 (HA1077)                                                             
REMARK 900 RELATED ID: 1XH5   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORSIN        
REMARK 900 COMPLEX WITH PROTEIN KINASE A AND MUTANTS                            
REMARK 900 RELATED ID: 1YDS   RELATED DB: PDB                                   
REMARK 900 STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTICSUBUNIT   
REMARK 900 IN COMPLEX WITH H8 PROTEIN KINASE INHIBITOR[N-(2-METHYLAMINO) ETHYL] 
REMARK 900 -5-ISOQUINOLINESULFONAMIDE                                           
REMARK 900 RELATED ID: 1STC   RELATED DB: PDB                                   
REMARK 900 CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT INCOMPLEX     
REMARK 900 WITH STAUROSPORINE                                                   
REMARK 900 RELATED ID: 2JDT   RELATED DB: PDB                                   
REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH ISOQUINOLINE-5-SULFONIC  
REMARK 900 ACID (2-(2-(4- CHLOROBENZYLOXY) ETHYLAMINO)ETHYL)AMIDE               
REMARK 900 RELATED ID: 1Q8T   RELATED DB: PDB                                   
REMARK 900 THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE(PKA) IN       
REMARK 900 COMPLEX WITH RHO- KINASE INHIBITOR Y-27632                           
REMARK 900 RELATED ID: 1XH8   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORSIN        
REMARK 900 COMPLEX WITH PROTEIN KINASE A AND MUTANTS                            
REMARK 999                                                                      
REMARK 999 SEQUENCE                                                             
REMARK 999 4 RESIDUES OF THE WILD-TYPE PKA SEQUENCE HAVE BEEN MUTATED           
REMARK 999 TO THE CORRESPONDING RESIDUES IN PKB                                 
DBREF  2VO3 A    0   350  UNP    P00517   KAPCA_BOVIN      1    351             
DBREF  2VO3 I    5    24  UNP    P61925   IPKA_HUMAN       6     25             
SEQADV 2VO3 THR A  104  UNP  P00517    VAL   105 ENGINEERED MUTATION            
SEQADV 2VO3 ALA A  123  UNP  P00517    VAL   124 ENGINEERED MUTATION            
SEQADV 2VO3 MET A  173  UNP  P00517    LEU   174 ENGINEERED MUTATION            
SEQADV 2VO3 LYS A  181  UNP  P00517    GLN   182 ENGINEERED MUTATION            
SEQRES   1 A  351  MET GLY ASN ALA ALA ALA ALA LYS LYS GLY SER GLU GLN          
SEQRES   2 A  351  GLU SER VAL LYS GLU PHE LEU ALA LYS ALA LYS GLU ASP          
SEQRES   3 A  351  PHE LEU LYS LYS TRP GLU ASN PRO ALA GLN ASN THR ALA          
SEQRES   4 A  351  HIS LEU ASP GLN PHE GLU ARG ILE LYS THR LEU GLY THR          
SEQRES   5 A  351  GLY SER PHE GLY ARG VAL MET LEU VAL LYS HIS MET GLU          
SEQRES   6 A  351  THR GLY ASN HIS TYR ALA MET LYS ILE LEU ASP LYS GLN          
SEQRES   7 A  351  LYS VAL VAL LYS LEU LYS GLN ILE GLU HIS THR LEU ASN          
SEQRES   8 A  351  GLU LYS ARG ILE LEU GLN ALA VAL ASN PHE PRO PHE LEU          
SEQRES   9 A  351  THR LYS LEU GLU PHE SER PHE LYS ASP ASN SER ASN LEU          
SEQRES  10 A  351  TYR MET VAL MET GLU TYR ALA PRO GLY GLY GLU MET PHE          
SEQRES  11 A  351  SER HIS LEU ARG ARG ILE GLY ARG PHE SEP GLU PRO HIS          
SEQRES  12 A  351  ALA ARG PHE TYR ALA ALA GLN ILE VAL LEU THR PHE GLU          
SEQRES  13 A  351  TYR LEU HIS SER LEU ASP LEU ILE TYR ARG ASP LEU LYS          
SEQRES  14 A  351  PRO GLU ASN LEU MET ILE ASP GLN GLN GLY TYR ILE LYS          
SEQRES  15 A  351  VAL THR ASP PHE GLY PHE ALA LYS ARG VAL LYS GLY ARG          
SEQRES  16 A  351  THR TRP TPO LEU CYS GLY THR PRO GLU TYR LEU ALA PRO          
SEQRES  17 A  351  GLU ILE ILE LEU SER LYS GLY TYR ASN LYS ALA VAL ASP          
SEQRES  18 A  351  TRP TRP ALA LEU GLY VAL LEU ILE TYR GLU MET ALA ALA          
SEQRES  19 A  351  GLY TYR PRO PRO PHE PHE ALA ASP GLN PRO ILE GLN ILE          
SEQRES  20 A  351  TYR GLU LYS ILE VAL SER GLY LYS VAL ARG PHE PRO SER          
SEQRES  21 A  351  HIS PHE SER SER ASP LEU LYS ASP LEU LEU ARG ASN LEU          
SEQRES  22 A  351  LEU GLN VAL ASP LEU THR LYS ARG PHE GLY ASN LEU LYS          
SEQRES  23 A  351  ASN GLY VAL ASN ASP ILE LYS ASN HIS LYS TRP PHE ALA          
SEQRES  24 A  351  THR THR ASP TRP ILE ALA ILE TYR GLN ARG LYS VAL GLU          
SEQRES  25 A  351  ALA PRO PHE ILE PRO LYS PHE LYS GLY PRO GLY ASP THR          
SEQRES  26 A  351  SER ASN PHE ASP ASP TYR GLU GLU GLU GLU ILE ARG VAL          
SEQRES  27 A  351  SEP ILE ASN GLU LYS CYS GLY LYS GLU PHE SER GLU PHE          
SEQRES   1 I   20  THR THR TYR ALA ASP PHE ILE ALA SER GLY ARG THR GLY          
SEQRES   2 I   20  ARG ARG ASN ALA ILE HIS ASP                                  
MODRES 2VO3 SEP A  139  SER  PHOSPHOSERINE                                      
MODRES 2VO3 TPO A  197  THR  PHOSPHOTHREONINE                                   
MODRES 2VO3 SEP A  338  SER  PHOSPHOSERINE                                      
HET    SEP  A 139      10                                                       
HET    TPO  A 197      11                                                       
HET    SEP  A 338      10                                                       
HET     CL  A1351       1                                                       
HET    M04  A1352      25                                                       
HETNAM     SEP PHOSPHOSERINE                                                    
HETNAM     TPO PHOSPHOTHREONINE                                                 
HETNAM      CL CHLORIDE ION                                                     
HETNAM     M04 1-[4-(4-CHLOROBENZYL)-1-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-           
HETNAM   2 M04  YL)PIPERIDIN-4-YL]METHANAMINE                                   
HETSYN     SEP PHOSPHONOSERINE                                                  
HETSYN     TPO PHOSPHONOTHREONINE                                               
FORMUL   1  SEP    2(C3 H8 N O6 P)                                              
FORMUL   1  TPO    C4 H10 N O6 P                                                
FORMUL   3   CL    CL 1-                                                        
FORMUL   4  M04    C19 H22 CL N5                                                
FORMUL   5  HOH   *341(H2 O)                                                    
HELIX    1   1 SER A   14  ASN A   32  1                                  19    
HELIX    2   2 HIS A   39  ASP A   41  5                                   3    
HELIX    3   3 LYS A   76  LEU A   82  1                                   7    
HELIX    4   4 GLN A   84  GLN A   96  1                                  13    
HELIX    5   5 GLU A  127  GLY A  136  1                                  10    
HELIX    6   6 GLU A  140  LEU A  160  1                                  21    
HELIX    7   7 LYS A  168  GLU A  170  5                                   3    
HELIX    8   8 ASP A  184  ALA A  188  5                                   5    
HELIX    9   9 THR A  201  LEU A  205  5                                   5    
HELIX   10  10 ALA A  206  LEU A  211  1                                   6    
HELIX   11  11 LYS A  217  GLY A  234  1                                  18    
HELIX   12  12 GLN A  242  GLY A  253  1                                  12    
HELIX   13  13 SER A  262  LEU A  273  1                                  12    
HELIX   14  14 VAL A  288  ASN A  293  1                                   6    
HELIX   15  15 HIS A  294  ALA A  298  5                                   5    
HELIX   16  16 ASP A  301  GLN A  307  1                                   7    
HELIX   17  17 THR I    5  SER I   13  1                                   9    
SHEET    1  AA 5 PHE A  43  GLY A  52  0                                        
SHEET    2  AA 5 GLY A  55  HIS A  62 -1  O  GLY A  55   N  GLY A  52           
SHEET    3  AA 5 HIS A  68  ASP A  75 -1  O  TYR A  69   N  VAL A  60           
SHEET    4  AA 5 ASN A 115  GLU A 121 -1  O  LEU A 116   N  LEU A  74           
SHEET    5  AA 5 LEU A 106  LYS A 111 -1  N  GLU A 107   O  VAL A 119           
SHEET    1  AB 2 LEU A 162  ILE A 163  0                                        
SHEET    2  AB 2 LYS A 189  ARG A 190 -1  O  LYS A 189   N  ILE A 163           
SHEET    1  AC 2 LEU A 172  ILE A 174  0                                        
SHEET    2  AC 2 ILE A 180  VAL A 182 -1  O  LYS A 181   N  MET A 173           
SHEET    1  AD 2 CYS A 199  GLY A 200  0                                        
SHEET    2  AD 2 ILE I  22  HIS I  23 -1  O  ILE I  22   N  GLY A 200           
LINK         C   PHE A 138                 N   SEP A 139     1555   1555  1.34  
LINK         C   SEP A 139                 N   GLU A 140     1555   1555  1.33  
LINK         C   TRP A 196                 N   TPO A 197     1555   1555  1.33  
LINK         C   TPO A 197                 N   LEU A 198     1555   1555  1.33  
LINK         C   VAL A 337                 N   SEP A 338     1555   1555  1.33  
LINK         C   SEP A 338                 N   ILE A 339     1555   1555  1.33  
SITE     1 AC1  4 LYS A  72  ASP A 184  M04 A1352  HOH A2109                    
SITE     1 AC2 17 GLY A  50  THR A  51  GLY A  52  GLY A  55                    
SITE     2 AC2 17 VAL A  57  ALA A  70  LEU A  74  THR A 104                    
SITE     3 AC2 17 GLU A 121  ALA A 123  GLU A 127  GLU A 170                    
SITE     4 AC2 17 ASN A 171  MET A 173  ASP A 184   CL A1351                    
SITE     5 AC2 17 HOH A2181                                                     
CRYST1   73.124   74.477   79.933  90.00  90.00  90.00 P 21 21 21    4          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      0.013675  0.000000  0.000000        0.00000                         
SCALE2      0.000000  0.013427  0.000000        0.00000                         
SCALE3      0.000000  0.000000  0.012510        0.00000